algaecytes limited Company Information
Company Number
07264317
Next Accounts
May 2026
Shareholders
kcp nominees ltd
nazir bhatt bashir
View AllGroup Structure
View All
Industry
Other research and experimental development on natural sciences and engineering
Registered Address
camburgh house, 27, new dover road, canterbury, kent, CT1 3DN
Website
www.algaecytes.comalgaecytes limited Estimated Valuation
Pomanda estimates the enterprise value of ALGAECYTES LIMITED at £2.2m based on a Turnover of £1.7m and 1.29x industry multiple (adjusted for size and gross margin).
algaecytes limited Estimated Valuation
Pomanda estimates the enterprise value of ALGAECYTES LIMITED at £0 based on an EBITDA of £-1.4m and a 5.89x industry multiple (adjusted for size and gross margin).
algaecytes limited Estimated Valuation
Pomanda estimates the enterprise value of ALGAECYTES LIMITED at £8m based on Net Assets of £3.9m and 2.03x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Algaecytes Limited Overview
Algaecytes Limited is a live company located in canterbury, CT1 3DN with a Companies House number of 07264317. It operates in the other research and experimental development on natural sciences and engineering sector, SIC Code 72190. Founded in May 2010, it's largest shareholder is kcp nominees ltd with a 50.5% stake. Algaecytes Limited is a established, small sized company, Pomanda has estimated its turnover at £1.7m with high growth in recent years.
Upgrade for unlimited company reports & a free credit check
Algaecytes Limited Health Check
Pomanda's financial health check has awarded Algaecytes Limited a 4.5 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 3 areas for improvement. Company Health Check FAQs


4 Strong

3 Regular

3 Weak

Size
annual sales of £1.7m, make it smaller than the average company (£4.2m)
- Algaecytes Limited
£4.2m - Industry AVG

Growth
3 year (CAGR) sales growth of 26%, show it is growing at a faster rate (7.9%)
- Algaecytes Limited
7.9% - Industry AVG

Production
with a gross margin of 48.7%, this company has a comparable cost of product (48.7%)
- Algaecytes Limited
48.7% - Industry AVG

Profitability
an operating margin of -82.6% make it less profitable than the average company (1.1%)
- Algaecytes Limited
1.1% - Industry AVG

Employees
with 13 employees, this is below the industry average (44)
13 - Algaecytes Limited
44 - Industry AVG

Pay Structure
on an average salary of £65.5k, the company has an equivalent pay structure (£65.5k)
- Algaecytes Limited
£65.5k - Industry AVG

Efficiency
resulting in sales per employee of £132k, this is equally as efficient (£129.6k)
- Algaecytes Limited
£129.6k - Industry AVG

Debtor Days
There is insufficient data available for this Key Performance Indicator!
- Algaecytes Limited
- - Industry AVG

Creditor Days
its suppliers are paid after 176 days, this is slower than average (44 days)
- Algaecytes Limited
44 days - Industry AVG

Stock Days
There is insufficient data available for this Key Performance Indicator!
- Algaecytes Limited
- - Industry AVG

Cash Balance
has cash to cover current liabilities for 104 weeks, this is more cash available to meet short term requirements (36 weeks)
104 weeks - Algaecytes Limited
36 weeks - Industry AVG

Debt Level
it has a ratio of liabilities to total assets of 17.9%, this is a lower level of debt than the average (39.1%)
17.9% - Algaecytes Limited
39.1% - Industry AVG
ALGAECYTES LIMITED financials

Algaecytes Limited's latest turnover from August 2024 is estimated at £1.7 million and the company has net assets of £3.9 million. According to their latest financial statements, Algaecytes Limited has 13 employees and maintains cash reserves of £1.2 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Aug 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | May 2012 | May 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | 0 | 0 | 0 | 0 | 0 | 0 | |||||||||
Other Income Or Grants | |||||||||||||||
Cost Of Sales | |||||||||||||||
Gross Profit | |||||||||||||||
Admin Expenses | |||||||||||||||
Operating Profit | |||||||||||||||
Interest Payable | 0 | 0 | 0 | 0 | 0 | 0 | |||||||||
Interest Receivable | 0 | 0 | 0 | 0 | 0 | 0 | |||||||||
Pre-Tax Profit | -1,074,302 | -1,758,791 | -742,640 | -709,175 | -537,796 | -459,302 | |||||||||
Tax | 174,860 | 132,976 | 72,712 | 126,302 | 169,072 | 0 | |||||||||
Profit After Tax | -899,442 | -1,625,815 | -669,928 | -582,873 | -368,724 | -459,302 | |||||||||
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | |||||||||
Retained Profit | -899,442 | -1,625,815 | -669,928 | -582,873 | -368,724 | -459,302 | |||||||||
Employee Costs | 597,029 | 563,429 | 472,179 | ||||||||||||
Number Of Employees | 13 | 15 | 12 | 12 | 10 | 14 | 12 | 12 | 12 | ||||||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Aug 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | May 2012 | May 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 873,587 | 914,453 | 977,952 | 1,094,529 | 458,771 | 491,475 | 536,404 | 571,437 | 404,881 | 262,141 | 265,366 | 271,961 | 952 | 1,166 | 2,333 |
Intangible Assets | 109,636 | 118,084 | 137,939 | 150,243 | 162,373 | 163,541 | 167,688 | 165,783 | 117,969 | 91,702 | 53,395 | 27,335 | 3,670 | 3,788 | 3,990 |
Investments & Other | 2,185,595 | 1,840,952 | 901,598 | 901,598 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Fixed Assets | 3,168,818 | 2,873,489 | 2,017,489 | 2,146,370 | 621,244 | 655,016 | 704,092 | 737,220 | 522,850 | 353,843 | 318,761 | 299,296 | 4,622 | 4,954 | 6,323 |
Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Debtors | 0 | 0 | 97 | 97 | 87 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4,820 | 9,745 | 40 |
Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Misc Debtors | 437,448 | 526,812 | 1,773,380 | 852,044 | 253,989 | 477,674 | 456,794 | 267,235 | 253,947 | 174,108 | 148,368 | 31,981 | 0 | 0 | 0 |
Cash | 1,183,965 | 429,153 | 655,772 | 1,600,534 | 112,134 | 14,343 | 80,176 | 448,298 | 514,480 | 232,462 | 44,011 | 7,288 | 3,405 | 12,501 | 520 |
misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current assets | 1,621,413 | 955,965 | 2,429,249 | 2,452,675 | 366,210 | 492,017 | 536,970 | 715,533 | 768,427 | 406,570 | 192,379 | 39,269 | 8,225 | 22,246 | 560 |
total assets | 4,790,231 | 3,829,454 | 4,446,738 | 4,599,045 | 987,454 | 1,147,033 | 1,241,062 | 1,452,753 | 1,291,277 | 760,413 | 511,140 | 338,565 | 12,847 | 27,200 | 6,883 |
Bank overdraft | 110,000 | 110,000 | 85,000 | 10,000 | 3,333 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 425,332 | 237,034 | 336,784 | 303,970 | 230,123 | 344,292 | 336,175 | 297,554 | 33,109 | 170,428 | 205,069 | 75,593 | 10,463 | 8,905 | 2,000 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1,358 | 1,358 | 1,358 | 5,758 | 0 | 15,758 | 13,765 |
other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 52,588 | 33,502 | 43,234 | 504,796 | 400,600 | 197,825 | 99,063 | 92,261 | 267,817 | 14,571 | 94,229 | 49,740 | 0 | 0 | 0 |
total current liabilities | 587,920 | 380,536 | 465,018 | 818,766 | 634,056 | 542,117 | 435,238 | 389,815 | 302,284 | 186,357 | 300,656 | 131,091 | 10,463 | 24,663 | 15,765 |
loans | 268,333 | 341,667 | 451,666 | 506,535 | 511,761 | 451,800 | 0 | 19,051 | 327,255 | 500,000 | 500,000 | 510,000 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 27,255 | 27,255 | 71,255 | 37,255 | 36,255 | 25,255 |
provisions | 0 | 0 | 0 | 0 | 0 | 0 | 47,603 | 43,991 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total long term liabilities | 268,333 | 341,667 | 451,666 | 506,535 | 511,761 | 451,800 | 47,603 | 63,042 | 327,255 | 527,255 | 527,255 | 581,255 | 37,255 | 36,255 | 25,255 |
total liabilities | 856,253 | 722,203 | 916,684 | 1,325,301 | 1,145,817 | 993,917 | 482,841 | 452,857 | 629,539 | 713,612 | 827,911 | 712,346 | 47,718 | 60,918 | 41,020 |
net assets | 3,933,978 | 3,107,251 | 3,530,054 | 3,273,744 | -158,363 | 153,116 | 758,221 | 999,896 | 661,738 | 46,801 | -316,771 | -373,781 | -34,871 | -33,718 | -34,137 |
total shareholders funds | 3,933,978 | 3,107,251 | 3,530,054 | 3,273,744 | -158,363 | 153,116 | 758,221 | 999,896 | 661,738 | 46,801 | -316,771 | -373,781 | -34,871 | -33,718 | -34,137 |
Aug 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | May 2012 | May 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||||||
Operating Profit | |||||||||||||||
Depreciation | 40,866 | 64,753 | 66,643 | 68,289 | 65,942 | 65,044 | 74,468 | 409,140 | 25,363 | 26,502 | 25,036 | 18,818 | 756 | 1,167 | 1,167 |
Amortisation | 8,448 | 12,673 | 12,658 | 12,637 | 13,008 | 10,656 | 8,599 | 6,435 | 577 | 256 | 226 | 223 | 118 | 202 | 51 |
Tax | 174,860 | 132,976 | 72,712 | 126,302 | 169,072 | 0 | |||||||||
Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors | -89,364 | -1,246,665 | 921,336 | 598,065 | -223,598 | 20,880 | 189,559 | 13,288 | 79,839 | 25,740 | 116,387 | 27,161 | 4,780 | 9,705 | 40 |
Creditors | 188,298 | -99,750 | 32,814 | 73,847 | -114,169 | 8,117 | 38,621 | 264,445 | -137,319 | -34,641 | 129,476 | 65,130 | 8,463 | 6,905 | 2,000 |
Accruals and Deferred Income | 19,086 | -9,732 | -461,562 | 104,196 | 202,775 | 98,762 | 6,802 | -175,556 | 253,246 | -79,658 | 44,489 | 49,740 | 0 | 0 | 0 |
Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | -47,603 | 3,612 | 43,991 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash flow from operations | |||||||||||||||
Investing Activities | |||||||||||||||
capital expenditure | |||||||||||||||
Change in Investments | 344,643 | 939,354 | 0 | 901,498 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
cash flow from investments | |||||||||||||||
Financing Activities | |||||||||||||||
Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1,358 | 0 | 0 | -4,400 | 5,758 | -13,765 | 1,993 | 13,765 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term loans | -73,334 | -109,999 | -54,869 | -5,226 | 59,961 | 451,800 | -19,051 | -308,204 | -172,745 | 0 | -10,000 | 510,000 | 0 | 0 | 0 |
Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -27,255 | 0 | -44,000 | 34,000 | 12,000 | 11,000 | 25,255 |
share issue | |||||||||||||||
interest | 0 | 0 | 0 | 0 | 0 | 0 | |||||||||
cash flow from financing | 638,716 | 1,654,411 | 1,084,865 | 946,445 | 367,334 | 670,150 | |||||||||
cash and cash equivalents | |||||||||||||||
cash | 754,812 | -226,619 | -944,762 | 1,488,400 | 97,791 | -65,833 | -368,122 | -66,182 | 282,018 | 188,451 | 36,723 | 3,883 | 2,885 | 11,981 | 520 |
overdraft | 0 | 25,000 | 75,000 | 6,667 | 3,333 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
change in cash | 754,812 | -251,619 | -1,019,762 | 1,481,733 | 94,458 | -65,833 | -368,122 | -66,182 | 282,018 | 188,451 | 36,723 | 3,883 | 2,885 | 11,981 | 520 |
algaecytes limited Credit Report and Business Information
Algaecytes Limited Competitor Analysis

Perform a competitor analysis for algaecytes limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other small companies, companies in CT1 area or any other competitors across 12 key performance metrics.
algaecytes limited Ownership
ALGAECYTES LIMITED group structure
Algaecytes Limited has 1 subsidiary company.
algaecytes limited directors
Algaecytes Limited currently has 3 directors. The longest serving directors include Mr Andrew Cosentino (Apr 2013) and Mr Ian Warwick (Jun 2015).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Andrew Cosentino | United Kingdom | 70 years | Apr 2013 | - | Director |
Mr Ian Warwick | United Kingdom | 65 years | Jun 2015 | - | Director |
Mr Ian Warwick | England | 65 years | Jun 2015 | - | Director |
P&L
August 2024turnover
1.7m
+8%
operating profit
-1.4m
0%
gross margin
48.7%
+3.47%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
August 2024net assets
3.9m
+0.27%
total assets
4.8m
+0.25%
cash
1.2m
+1.76%
net assets
Total assets minus all liabilities
algaecytes limited company details
company number
07264317
Type
Private limited with Share Capital
industry
72190 - Other research and experimental development on natural sciences and engineering
incorporation date
May 2010
age
15
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
August 2024
previous names
N/A
accountant
-
auditor
-
address
camburgh house, 27, new dover road, canterbury, kent, CT1 3DN
Bank
-
Legal Advisor
-
algaecytes limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to algaecytes limited.
algaecytes limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for ALGAECYTES LIMITED. This can take several minutes, an email will notify you when this has completed.
algaecytes limited Companies House Filings - See Documents
date | description | view/download |
---|